416
Participants
Start Date
March 30, 2017
Primary Completion Date
October 20, 2018
Study Completion Date
August 18, 2022
Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System, sizes 2.0 mm - 4.0 mm
Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System, sizes 4.5 mm - 5.0 mm
Ziekenhuis Oost Limburg - Campus Sint-Jan, Genk
C.H.U. de Charleroi, Charleroi
NYU Langone Medical Center, New York
Columbia University Medical Center/NewYork Presbyterian Hospital, New York
University of Virginia Medical Center, Charlottesville
Centre Hospitalier Universitaire Besancon - Hôpital Jean Minjoz, Besançon
Tallahassee Memorial Hospital, Tallahassee
North Florida Regional Medical Center, Gainesville
Morton Plant Hospital, Clearwater
TriStar Centennial Medical Center, Nashville
Baptist Memorial Hospital-Memphis, Memphis
University Hospitals Cleveland Medical Center, Cleveland
Saint Vincent Hospital (Green Bay WI), Green Bay
Abbott Northwestern Hospital, Minneapolis
Mercy Hospital (Coon Rapids MN), Coon Rapids
Nebraska Medicine, Omaha
Desert Springs Hospital Medical Center, Las Vegas
Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s, Banská Bystrica
Huntsville Hospital, Huntsville
Scripps Green Hospital, La Jolla
Riverside Community Hospital, Riverside
Hartford Hospital, Hartford
WellStar Kennestone Hospital, Marietta
University of Michigan Health System - University Hospital, Ann Arbor
North Shore University Hospital, Manhasset
Saint Joseph's Hospital Health Center, Syracuse
Houston Methodist Hospital, Houston
CHU Toulouse - Hôpital Rangueil, Toulouse
Lead Sponsor
Medtronic Vascular
INDUSTRY